David Katz to Bacteremia
This is a "connection" page, showing publications David Katz has written about Bacteremia.
Connection Strength
1.350
-
Ben-Chetrit E, Mc Gann P, Maybank R, Stam J, Assous MV, Katz DE. Colistin-resistant?Klebsiella pneumoniae?bloodstream infection: old drug, bad bug. Arch Microbiol. 2021 Aug; 203(6):2999-3006.
Score: 0.688
-
Ben-Chetrit E, Eldaim MA, Bar-Meir M, Dodin M, Katz DE. Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum ?-lactamase-producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia. Int J Antimicrob Agents. 2019 Apr; 53(4):423-428.
Score: 0.587
-
Rehm S, Campion M, Katz DE, Russo R, Boucher HW. Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy. J Antimicrob Chemother. 2009 May; 63(5):1034-42.
Score: 0.075